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Abstract
Background The Patient-rated Wrist Evaluation (PRWE)
is a commonly used instrument in upper extremity surgery
and in research. However, to recognize a treatment effect
expressed as a change in PRWE, it is important to be aware
of the minimum clinically important difference (MCID)
and the minimum detectable change (MDC). The MCID of
an outcome tool like the PRWE is defined as the smallest
change in a score that is likely to be appreciated by a
patient as an important change, while the MDC is defined
as the smallest amount of change that can be detected by an
outcome measure. A numerical change in score that is less
than the MCID, even when statistically significant, does
not represent a true clinically relevant change. To our
knowledge, the MCID and MDC of the PRWE have not
been determined in patients with distal radius fractures.
Questions/Purposes We asked: (1) What is the MCID of
the PRWE score for patients with distal radius fractures?
(2) What is the MDC of the PRWE?
Methods Our prospective cohort study included 102
patients with a distal radius fracture and a median age of 59
years (interquartile range [IQR], 48–66 years). All patients
completed the PRWE questionnaire during each of two
separate visits. At the second visit, patients were asked to
indicate the degree of clinical change they appreciated
since the previous visit. Accordingly, patients were cate-
gorized in two groups: (1) minimally improved or (2) no
change. The groups were used to anchor the changes
observed in the PRWE score to patients’ perspectives of
what was clinically important. We determined the MCID
using an anchor-based receiver operator characteristic
method. In this context, the change in the PRWE score was
considered a diagnostic test, and the anchor (minimally
improved or no change as noted by the patients from visit
to visit) was the gold standard. The optimal receiver
operator characteristic cutoff point calculated with the
Youden index reflected the value of the MCID.
Results In our study, the MCID of the PRWE was 11.5
points. The area under the curve was 0.54 (95% CI,
0.37–0.70) for the pain subscale and 0.71 (95% CI,
0.570.85) for the function subscale. We determined the
MDC to be 11.0 points.
Conclusions We determined the MCID of the PRWE
score for patients with distal radius fractures using the
anchor-based approach and verified that the MDC of the
PRWE was sufficiently small to detect our MCID.
Clinical Relevance We recommend using an improve-
ment on the PRWE of more than 11.5 points as the smallest
clinically relevant difference when evaluating the effects of
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treatments and when performing sample-size calculations
on studies of distal radius fractures.
Introduction
A frequently used outcome measure in distal radius frac-
ture studies is the Patient-rated Wrist Evaluation (PRWE)
score [8, 15]. The PRWE is a 15-item questionnaire
designed to measure a patient’s wrist pain and disability. It
consists of two subscales (pain and function) and has a
score range from 0 (no disability) to 100 (severe disability).
To recognize a treatment effect expressed as a change in
PRWE score, it is important to be aware of the minimum
clinically important difference (MCID) of the PRWE score.
The MCID represents the smallest change in score that
would be perceived by the patient as beneficial [4, 10, 21].
Consequently, a numeric change in score that is less than
the MCID, even if statistically significant, does not repre-
sent a true clinically relevant change. Because the MCID
defines a difference that is considered important to patients,
the MCID also serves as the basis for estimating the nec-
essary sample size in designing future studies [20].
Another important instrument is the minimum detect-
able change (MDC). The MDC is the smallest amount of
change that falls outside the measurement error of an
instrument. Therefore, any change smaller than the MDC
could be the result of the variability of the questionnaire.
To ensure that the MDC is sufficiently small to detect the
MCID, the MCID should be greater than the MDC.
The MCID and the MDC of the PRWE have been
examined in patients with chronic wrist conditions [12, 20,
22]; however, to our knowledge, they have not been
determined in patients with a distal radius fracture.
Therefore, the purpose of our study was to determine the
MCID and MDC of the PRWE score in patients with distal
radius fractures.
Patients and Methods
Our prospective cohort study was conducted alongside two
ongoing clinical trials that are coordinated from our insti-
tution, an academic Level-1 trauma center in The
Netherlands. The medical ethical review committee gran-
ted approval before initiation of this parallel study, without
the need for informed consent from patient participants.
Patients for our cohort study were recruited from the two
ongoing clinical trials between January 2011 and July
2014, during their first visit to the outpatient clinic. To
increase the size of our cohort study population, we also
recruited patients with distal radius fractures at the outpa-
tient clinic who were not enrolled in the clinical trials. The
patients who were not participants of the clinical trial were
enrolled in our study between January 2014 and July 2014.
Our study population consisted of 102 patients with
distal radius fractures. Patients were excluded if they: (1)
did not want to complete the questionnaire at the outpatient
clinic; (2) did not complete the anchor questions; (3) were
unable to understand the study information; or (4) had
sustained their distal radius fracture more than 1 year
before their visit to the outpatient clinic.
Of the two concurrent clinical trials occurring during our
prospective cohort study, the first trial [3] included 42
patients who underwent a study of two- and three-dimen-
sional imaging. This trial provided 42 adult patients with
intraarticular distal radius fractures who were treated with
open reduction and internal fixation with a volar locking
plate.
The second trial [25] randomized patients with displaced
extraarticular distal radius fractures (AO types A2 and A3
[17]) between treatment with either open reduction and
internal fixation with a volar locking plate or plaster
immobilization. This trial provided 39 patients.
Additionally, during the first 6 months of 2014, we
identified 55 patients who were not enrolled in either
clinical trial but who were eligible for participation in our
study. All adult patients with a distal radius fracture were
eligible for inclusion, regardless of the type of treatment
they received. After exclusion, an additional 21 patients
with a distal radius fracture who were not enrolled in either
of the two trials were included in our study cohort.
There are two methods to define the MCID: (1) a dis-
tribution-based and (2) an anchor-based approach [5]. The
distribution-based approach is used to evaluate if the
observed effect is attributable to true change or simply the
variability of the questionnaire. It examines the distribution
of observed scores in a group of patients. The magnitude of
the effect is interpreted in relation to variation of the
instrument [9]. In other words, is the observed effect
attributable to true change or simply the variability of the
questionnaire?
The anchor-based approach uses an external criterion
(the anchor) to determine the MCID. Possible anchors
include objective measurements, such as prehensile grip
strength and ROM, or patient-reported anchor questions.
The purpose of a patient-reported anchor question is to
‘‘anchor’’ the changes observed in the PRWE score to
patients’ perspectives of what is clinically important [13].
Anchor-based methods to determine the MCID are
preferred because an external criterion is used to define
what is clinically important [7]; however, the anchor-based
method does not take into account the measurement error
of the instrument, so it is valuable to use the anchor- and
distribution-based approaches [7]. To avoid confusion, the
distribution-based method generally is referred to as
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minimum detectable change (MDC), and the anchor-based
method as MCID [7]. We use the same terms to identify the
methods.
Data were collected prospectively. Patients completed
the Dutch version of the PRWE questionnaire during two
visits at approximately 6 to 12 weeks and approximately 12
to 52 weeks after distal radius fracture injury.
At the second visit, patients were asked to indicate the
degree of clinical change they had noticed since the pre-
vious visit for each domain (pain and function). Patients
noted their answers on a global rating of change scale
(GRC) from 5 (much worse) to +5 (much better) (Fig. 1)
[11]. The purpose of this question was to ‘‘anchor’’ the
changes observed in the PRWE score to patients’ per-
spectives regarding what is clinically important [13].
There is no consensus regarding the required sample
size to determine the MCID [19]. We made a sample size
estimation based on a conservatively estimated MCID of
12 points, with a SD of ± 14 [12, 20, 22]. To achieve an a
of 0.05 and a power of 80%, we required 18 data points
representing no change, and 18 data points representing
minimal improvement.
Statistical Methods
The number of questions not answered by patients com-
prised less than 5% for all items and were replaced with the
mean score of the subscale according to the PRWE user
manual [14]. PRWE scores were calculated for both
subscales (pain and function) using the published algorithm
[14]. The change in outcome was calculated as the differ-
ence between the last and the first scores. The change in
score between visits was transformed such that improve-
ment was indicated by a positive value. We reported
medians and interquartile ranges (IQR) for nonparametric
variables, and means (± SD) for normally distributed
variables. The Kolmogorov-Smirnov test was used to
determine if a variable was normally distributed. A p value
of 0.05 or less was considered statistically significant. Data
entry and analysis were performed using SPSS1 (Version
20.0; IBM Corp, Armonk, NY, USA) and RStudio Version
3.1.2; RStudio, Boston, MA, USA), with the package
coefficient alpha.
Determination of MDC
We calculated the MDC for the pain and function subscales
separately and summed them to obtain the total MDC [7].
The MDCs were calculated as:
z score 90%ð Þ 
p
2  Standard Error of MeasurementPRWE
A z score of 1.65 was chosen to reflect a 90% one-sided
CI, similar to previous studies [12, 20]. The standard error
of measurement is a measure of the instrument variability
and takes into account the distribution of repeated
measures on a questionnaire around the ‘‘true’’ score of a
patient. For our study, the standard error of measurement
was calculated by multiplying the SD (r) of the PRWE
Fig. 1 The global rating of change (GRC) scale used in the Patient-rated Wrist Evaluation (PRWE) questionnaire is shown. The anchor
questions allowed patients to assess their current health status regarding wrist function and wrist pain, and compare their status with that of their
previous visit.
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score at the second followup, by the square root of 1, minus
the reliability coefficient (r) of the instrument, or, in
formula [1, 7]:
Standard Error of Measurement ¼ r  p ð1rÞ
The reliability coefficient is the overall consistency of
an instrument. We used Cronbach’s alpha as a parameter of
reliability [2]. Cronbach’s alpha is used to measure the
internal consistency of a (sub)scale. Its value can range
from 0 to 1.0, where greater than 0.7 indicates good
internal consistency [2].
Determination of the MCID
We calculated the MCID according the receiver operating
characteristic (ROC) curve method [6, 12]. In this context,
the change in PRWE score was considered a diagnostic test
and the anchor was the gold standard [6]. The ROC curve
plots the sensitivity against 1-specificity for all possible
cutoff points of the change in PRWE score. The optimal
ROC cutoff point is the value for which the sum of per-
centages of false positive and false negative classifications is
smallest ([1-sensitivity] + [1-specificity]) [6]. This value
represents the MCID. The area under the ROC curve reflects
the ability of the change in PRWE score to differentiate
between patients with and without clinically important
change. The area under the ROC curve ranges from 0.5 to 1;
a higher score indicates better discrimination.
Consistent with previous studies [22, 24], patients were
categorized in five groups according to their answer to the
anchor question: 5 to 4 (marked worsening); 3 to 2
(minimal worsening); 1 to 1 (no change); 2 to 3 (minimal
improvement); and 4 to 5 (marked improvement). We cal-
culated the MCID by plotting the ROC of the change in
PRWE score for patients in the minimal-improvement group
compared with patient scores in the no-change group.
We tested for significant score changes among patients
who indicated they had experienced marked worsening,
minimal worsening, no change, minimal improvement, and
marked improvement, using the Kruskal-Wallis test. Non-
significant differences among the five patient categories
could suggest that the improvement categories were not
sufficiently discriminative. The adequateness of the GRC
scale was explored by quantifying the correlation between
change in PRWE scores and the anchor questions using
Spearman’s rho. Correlation coefficients were interpreted
as negligible correlation (0–0.3); low correlation (0.3–0.5);
moderate correlation (0.5–0.7); high correlation (0.7–0.9);
or very high correlation (0.9–1.0) [16]. A total 102 patients
were included in our study (Fig. 2). Patient characteristics
are provided (Table 1).
Results
MCID of the PRWE for Patients with Distal Radius
Fractures
The overall MCID was 11.5 points on the PRWE
(Table 2). For the pain subscale, 20% of the patients (20/
102) indicated they had experienced minimal improvement
and 37% (38/102) experienced no change. The area under
the ROC curve of the change in PRWE score to
Eligible Patients in Outpatient 
Clinic
(January 2014 to July 2014)
n = 55
Excluded Patients
n = 34 (62%)
Reasons:
Refused to Fill in Questionnaire: n = 1 (2%)
Did Not Complete Both Questionnaires: n = 13 (24%)
Sustained Fracture More Than 1 Year Ago: n = 11 (20%)
Was Referred to Other Department/Hospital: n = 3 (5 %)
Missed in Outpatient Clinic: n = 6   (11%)
Patients Included in the Study
n = 102
Patients Enrolled From Trial 1
n = 42





Fig. 2 The flowchart shows patient selection methods used for the study.
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differentiate between patients with minimal improvement
in pain and patients with no change in pain was 0.54 (95%
CI, 0.37–0.70). For the function subscale, 24% of the
patients (24/102) reported minimal improvement in func-
tion and 34% (35/102) experienced no change. The area
under the ROC curve of the change in PRWE score to
differentiate between patients with minimal improvement
in function and no change in function was 0.71 (95% CI,
0.570.85).
MDC of the PRWE
The MDC was 11.0 points. The majority of patients
reported marked improvement (Table 3) and the PRWE
scores between the first and the second measurements
differed (p\ 0.001; Wilcoxon signed rank test). For the
pain subscale, 40 patients reported marked improvement
(change in PRWE, 9.5; IQR, 5.0–16.0), and 20 patients had
minimal improvement (change in PRWE, 5.0; IQR, 1.8
to 10.7). For the function subscale, 41 patients reported
marked improvement (change in PRWE, 12.5; IQR,
5.8–19.7), and 24 patients had minimal improvement
(change in PRWE, 10.8; IQR, 3.6–18.8).
There were significant differences in the changes in
PRWE scores among patients who indicated they had
experienced marked worsening, minimal worsening, no
change, minimal improvement, or marked improvement in
pain (p = 0.001, Kruskal-Wallis test), suggesting suffi-
ciently discriminative categories (Table 3). There also
were significant differences in the changes in PRWE scores
among the categories of the function subscale (p\ 0.001,
Kruskal-Wallis test).
There was correlation between the change in PRWE
scores for the pain subscale and the GRC categories, con-
firming the adequacy of the GRC (correlation
coefficient = 0.39; two-tailed p\ 0.001). The correlation
between the change in PRWE score and GRC categories
for function was similar (correlation coefficient = 0.34;
two-tailed p = 0.001). Reliability coefficients (Cronbach’s
alpha) were 0.98 for the pain subscale and 0.95 for the
function subscale, indicating good internal consistency of
the questionnaire.
Discussion
The PRWE score is a well-accepted measure of patient
functional outcome after distal radius fracture [8].
Knowledge of the MCID of the PRWE provides a useful
benchmark to interpret study results and a basis for sample-
size calculations. Three previous studies have examined the
MCID of the PRWE; however, to our knowledge, no such
study has examined patients with distal radius fractures
[12, 20, 22]. Some authors advocate that the MCID is not a
universal fixed attribute and cannot be applied across
patient populations or disease-specific states [4, 19, 26, 27].
The MCID can fluctuate based on what is interpreted as
important to the patient; therefore, patients with chronic
wrist conditions may have other expectations from treat-
ment than patients with an acute condition. Patients who
sustain a distal radius fracture generally have their healthy
wrist become immobilized, are in pain, and experience a
(temporary) complete loss of wrist function. Their standard
of comparison is likely not the painful situation at the
beginning of treatment for the fracture, but their status
before the injury [18]. In general, these patients expect
complete recovery, which could entail that they require
different changes in PRWE scores to appreciate clinical
improvement.
Table 1. Characteristics of study population (n = 102)
Characteristic Numbers
Age, median year (IQR) 59 (48–66)
Women, n (%) 71 (70)
Dominant hand affected, n (%) 50 (49)




Type of treatment, n (%)
Open reduction and volar locking plate, n (%) 65 (64)
Plaster, n (%) 36 (35)
None*, n (%) 1 (1)
Weeks from trauma to first measurement,
median (IQR)
8 (6–13)
Weeks between measurements, median (IQR) 8 (6–39)
Weeks from trauma to second measurement,
median (IQR)
16 (13–52)
PRWE score at first measurement, median (IQR) 44 (21–63)
PRWE score at second measurement, median (IQR) 17 (4–45)
* Patient was treated elsewhere and the fracture was missed;
IQR = interquartile range; PRWE = Patient-rated Wrist Evaluation.
Table 2. MCID and the MDC of the PRWE score
Subscale MCID* MDC*
PRWE pain 1.5 6.5
PRWE function 10 4.5
PRWE total 11.5 11.0
* Units are expressed in points on the PRWE score; MCID = mini-
mal clinically important difference; MDC = minimal detectable
change; PRWE = Patient-rated Wrist Evaluation.
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In our patients, the MCID was 11.5 points, which was
just outside the measurement error (MDC) of the PRWE
score.
Our study had several limitations. The majority of
patients were selected from one of two ongoing clinical trials
coordinated from our institution. Owing to the nature of the
trials, the patients in our study were part of a more selective
group of patients. All patients had a sustained displaced
distal radius fracture and consented to participate in a ran-
domized controlled trial. Such a select group of patients may
limit the generalizability of our results. Other limitations
pertain to the various approaches for determining theMCID.
For example, a limitation of the anchor-based approach is
that it does not take measurement precision into account [5,
7]; therefore, the MCID determined potentially can be
within the measurement error of the questionnaire. By
determining the MDC, it becomes possible to judge whether
the MDC of a measurement instrument is sufficiently small
to detect theMCID [7]. In our study, theMDCwas 11 points,
therefore the MCID we determined was outside the mea-
surement error of the questionnaire. Another limitation of
the anchor-based method is the possibility of recall bias [23]
Recall bias implies that patients are unable to recall their
initial state at the time of injury. Recall bias was present in
our study, illustrated by the low correlation we found
between the change in scores and the anchor questions;
however, none of the patients gave contradicting answers
(indicating worsening status in response to the anchor
questions while their PRWE score had improved, or vice
versa). The relatively short duration between measurements
(8 weeks) might have contributed to this. An increased
duration of followup in a study is associated with larger
estimates of the MCID [24], therefore we chose to limit the
followup to 1 year, similar to that in a previous study on the
MCID of the PRWE in patients with traumatic upper-ex-
tremity conditions [22].
The MCID for our patients was 11.5 points, which was
lower than previously determined MCIDs. Three previous
studies have examined the MCID of the PRWE. Schmitt
and Di Fabio [20] reported a MCID of 24 points in a cohort
of 211 patients, however their patients predominantly had
shoulder pain, and the PRWE is not intended for patients
with shoulder injuries. The second study, by Sorensen et al.
[22], included 102 patients with a traumatic upper-ex-
tremity conditions such as isolated tendinitis, arthritis, and
nerve compression syndrome. The MCID in that study was
14 points. The third study included 31 patients who
underwent ulnar-shortening osteotomy for ulnar impaction
syndrome and the MCID was 17 points [12].
The MDC is the smallest change in score that likely
reflects true change rather than measurement error. It shows
which changes fall outside the measurement error of the
health status measurement (based on, for instance, internal
validity or test-retest reliability) [7]. To ensure that the
MDC is sufficiently small to detect the MCID, it should be
greater than the MDC. We found an MDC of 11.0 points,
similar to the MDCs reported by Kim and Park (7.7 points)
[12] and Schmitt and Di Fabio (12.2 points) [20]. This value
for the MDC indicates that the PRWE questionnaire is able
to detect changes as small 11.0 points, therefore the PRWE
should be able to detect the MCID we determined.
In our prospective cohort study, we determined the
MCID of the PRWE for patients with distal radius fractures
using the anchor-based approach and verified that the MDC
of the PRWE was sufficiently small to detect our MCID.
The MCID is not a value that can be used to classify indi-
vidual treatment results, but rather a method to put group-
level treatment effects in perspective. We recommend using
an improvement on the PRWE of more than 11.5 points as
the smallest clinically relevant difference when evaluating
the effects of treatments and when performing sample-size
calculations on studies of distal radius fractures.
Table 3. Changes in Patient-rated Wrist Evaluation scores
Anchor category
Marked worsening Minimal worsening No change Minimal improvement Marked improvement p value*
(n = 1) (n = 3) (n = 38) (n = 20) (n = 40)
Pain subscale
Change, median (IQR) Not applicable 8.0 (15 to 5.0) 4.0 (0.0–10.9) 5.0 (1.8 to 10.7) 9.5 (5.0–16.0) 0.001
Anchor category
Marked worsening Minimal worsening No change Minimal improvement Marked improvement p value*
(n = 1) (n = 1) (n = 35) (n = 24) (n = 41)
Function subscale
Change, median (IQR) Not applicable Not applicable 3.5 (0.0–6.5) 10.8 (3.6–18.8) 12.5 (5.8–19.7) \0.001
* Kruskal-Wall test used for determining significance; IQR, interquartile range.
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